Sandra Philipp

1. Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label CADMUS Jr study
   2020/03/16 by S. Philipp, Sandra Philipp, Alan Menter +20 · 25 citations
   Immunology and Microbiology · Medicine · #Psoriasis: Treatment and Pathogenesis #Spondyloarthritis Studies and Treatments #Autoimmune and Inflammatory Disorders Research